Cancer management software firm Ziliomics has received funding from the Prospects Oncology Fund to develop its Heliotrope product . While the value of the cash injection has n't been revealed , Ziliomics said the deal would allow it to win more corporate clients and access more financing . It was designed by genomic experts at the Ontario Institute for Cancer Research . It uses artificial intelligence to analyze genomic data and enable doctors to make decisions on patients ' cancer treatments .
Cancer management software firm Ziliomics has received backing from the Prospects Oncology Fund to develop its Heliotrope product. While the value of the cash injection hasn't been revealed, Ziliomics said the deal would enable it to win more corporate clients and access more financing. Heliotrope was designed by genomic experts at the Ontario Institute for Cancer Research. It uses artificial intelligence to process genomic data and enable doctors to make decisions on patients' cancer treatments.